Paul Stroobant talks about taking proteomics from bench to bedside in this 3-minute video.
The field of proteomics has made great strides in multiple areas of research, and there is a great potential for using proteomics to detect early disease. Research groups such as the group directed by Paul Stroobant and others are diligently working to better understand changes that occur in the proteome during a particular disease state.
The technology and instrumentation has also improved, compared with the early days of proteomics research. Based on direct feedback from researchers, mass spectrometers and other instruments are becoming increasingly sensitive, and able to generate reliable results in a matter of hours. Based on the tireless work from researchers and the ever advancing instrumentation, we anticipate seeing great progress as the focus shifts from bench to bedside.
Post Author: Emily Humphreys. As a biology undergraduate at the University of Utah, Emily balanced a heavy class schedule while working long hours in a lab studying eye development. Following graduation, she became involved in infectious disease and aging research involving SNPS.
While she enjoyed the thrill of research, Emily has since traded bench work for science journalism.
And has been a regular contributor to Accelerating Science since 2012.